lvv-hemorphin-7 has been researched along with divalinal-angiotensin iv in 3 studies
| Studies (lvv-hemorphin-7) | Trials (lvv-hemorphin-7) | Recent Studies (post-2010) (lvv-hemorphin-7) | Studies (divalinal-angiotensin iv) | Trials (divalinal-angiotensin iv) | Recent Studies (post-2010) (divalinal-angiotensin iv) |
|---|---|---|---|---|---|
| 59 | 0 | 14 | 16 | 0 | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albiston, AL; Chai, SY; Lew, RA; McDowall, SG; Mustafa, T; Ye, S | 1 |
| Albiston, AL; Allen, AM; Barrett, GL; Chai, SY; Lee, J; McDowall, SG; Mendelsohn, FA; Morris, MJ; Murphy, M; Ping, SE | 1 |
| Beyer, CE; Dwyer, JM; Lin, Q; Ling, HP; Luo, B; Mark, RJ; Neal, S; Platt, BJ; Rosenzweig-Lipson, S; Schechter, LE | 1 |
3 other study(ies) available for lvv-hemorphin-7 and divalinal-angiotensin iv
| Article | Year |
|---|---|
Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP).
Topics: Aminopeptidases; Angiotensin II; Angiotensin Receptor Antagonists; Binding, Competitive; Cell Line; Cystinyl Aminopeptidase; Enzyme Activation; Enzyme Inhibitors; Hemoglobins; Humans; Kidney; Leucine; Ligands; Oligopeptides; Peptide Fragments; Peptides; Receptors, Angiotensin; Recombinant Proteins; Substrate Specificity | 2003 |
Effect of I.C.V. injection of AT4 receptor ligands, NLE1-angiotensin IV and LVV-hemorphin 7, on spatial learning in rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Avoidance Learning; Behavior, Animal; Hemoglobins; Injections, Intraventricular; Learning; Male; Oligopeptides; Peptide Fragments; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Angiotensin; Spatial Behavior; Time Factors | 2004 |
Angiotensin IV elevates oxytocin levels in the rat amygdala and produces anxiolytic-like activity through subsequent oxytocin receptor activation.
Topics: Amygdala; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Depression; Dose-Response Relationship, Drug; Exploratory Behavior; Hemoglobins; Immunoassay; Injections, Intraperitoneal; Injections, Intraventricular; Injections, Subcutaneous; Ligands; Male; Mice; Microdialysis; Oxytocin; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Receptors, Oxytocin; Time Factors; Up-Regulation | 2010 |